*New Hampshire Editor Tipoffs Newsletter for Tuesday April 29, 2025 ( 19 items ) |
Congressional Delegation Presses for Urgent Risk Assessment of Portsmouth Memorial Bridge
WASHINGTON, April 28 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release:
* * *
Congressional Delegation Presses for Urgent Risk Assessment of Portsmouth Memorial Bridge
WASHINGTON, D.C. - Today Congressman Chris Pappas (NH-01), a member of the House Transportation and Infrastructure Committee, led Senator Jeanne Shaheen (NH), Senator Maggie Hassan (NH), and Congresswoman Maggie Goodlander (NH-02) in urging the Federal Highway Administration (FHWA) to work expeditiously
more
Contracts for April 28, 2025
WASHINGTON, April 28 -- The U.S. Department of Defense issued the following news:
* * *
Contracts for April 28, 2025
ARMY
General Dynamics Ordnance and Tactical Systems Inc., St. Petersburg, Florida, was awarded a $727,803,978 firm-fixed-price contract to procure 120 mm Insensitive Munition High Explosive with Tracer tank ammunition cartridges. Bids were solicited via the internet with one received. Work locations and funding will be determined with each order, with an estimated completion
more
EPA Administrator Zeldin Announces Major Actions to Combat PFAS Contamination
WASHINGTON, April 28 -- The Environmental Protection Agency issued the following news release:
* * *
Administrator Zeldin Announces Major EPA Actions to Combat PFAS Contamination
WASHINGTON - U.S. Environmental Protection Agency (EPA) Administrator Lee Zeldin outlined upcoming agency action to address Per- and Polyfluoroalkyl Substances (PFAS). In this suite of actions, Administrator Zeldin announced a long list that included in part the designation of an agency lead for PFAS, the creation of
more
FDA Issues Warning Letter to Ecig Charleston
WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Ecig Charleston LLC:
* * *
To: Ecig Charleston LLC, 1836 Ashley River Road, Suite Q1, Charleston, SC 29407, United States
To Whom It May Concern,
The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that Ecig Charleston LLC manufactures, sells and/or distributes e-liquid p
more
FDA Issues Warning Letter to Ecig South
WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Ecig South LLC:
* * *
To: Ecig South LLC, 7250 Rivers Avenue, Suite 7, Charleston, SC 29406, United States
To Whom It May Concern:
The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that ECig Charleston manufactures, sells and/or distributes e-liquid products to customer
more
FDA Issues Warning Letter to Kure CBD & Vape
WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Alohma LLC, dba Kure CBD & Vape:
* * *
To: Alohma, LLC, d/b/a Kure CBD & Vape, 2390 North Diers Avenue, Grand Island, NE 68803, United States
To Whom It May Concern:
The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that My Vapor Den Inc, d/b/a Nu Age Smoke & Vape sells
more
FDA Issues Warning Letter to Mountain Vapor
WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Silver Moon Nutraceuticals LLC, dba Mountain Vapor:
* * *
To: Silver Moon Nutraceuticals, LLC, d/b/a Mountain Vapor, 111 Fletcher Commercial Drive, Suite B, Fletcher, NC 28732, United States
To Whom It May Concern:
The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that
more
FDA Issues Warning Letter to Nu Age Smoke & Vape
WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to My Vapor Den Inc. dba Nu Age Smoke & Vape:
* * *
To: My Vapor Den Inc, d/b/a Nu Age Smoke & Vape, 1006 North East End Boulevard Suite B, Marshall, TX 75670, United States
To Whom It May Concern:
The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that My Vapor Den Inc, d/
more
FDA Issues Warning Letter to Sparky's Electronic Cigarettes
WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Sparky's Electronic Cigarettes:
* * *
To: Sparky's Electronic Cigarettes, 2060 West River Road, Tucson, AZ 85704, United States
To Whom It May Concern:
The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that Sparky's Electronic Cigarettes manufactures, sells and/or distr
more
FDA Issues Warning Letter to Texas I-35 Vape
WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to NES21 LLC, dba Texas I-35 Vape:
* * *
To: NES21 LLC, d/b/a Texas I-35 Vape, 640 South Stemmons Street, Suite 200, Sanger, TX 76266, United States
To Whom It May Concern:
The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that NES21 LLC, d/b/a Texas I-35 Vape manufactures
more
FDA Issues Warning Letter to Vanity Vapor
WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Vanity Vapor:
* * *
To: Vanity Vapor, 15557 West Roosevelt Street, Suite 105, Goodyear, AZ 85338, United States
To Whom It May Concern:
The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that Vanity Vapor manufactures, sells and/or distributes e-liquid products to custom
more
FDA Releases Public Communication From College of American Pathologists
WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated April 7, 2025, from the College of American Pathologists:
* * *
To: The Honorable Martin A. Makary M.D., M.P.H.
Commissioner
US Food and Drug Administration (FDA)
10903 New Hampshire Avenue
Silver Spring, MD 20993
Re: Artificial Intelligence Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendation
more
FDA Releases Public Communication From Connected Health Initiative
WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated April 7, 2025, from the Connected Health Initiative:
* * *
To: Commissioner Martin Makary
U.S. Food & Drug Administration
Center for Devices and Radiological Health
10903 New Hampshire Ave
Silver Spring, Maryland 20993-0002
RE: Comments of the Connected Health Initiative to the Food and Drug Administration, Draft Guidance for Industry
more
FDA Releases Public Communication From Gerontological Society
WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated April 7, 2025, from the Gerontological Society of America:
* * *
To: Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, M.D. 20993
Re: Evaluation of Sex-Specific and Gender-Specific Data in Medical Device Clinical Studies; Draft Guidance for Industry and Food and Drug Administration Staff
* * *
On behalf of the Gero
more
FDA Releases Public Communication From Guttmacher Institute
WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated April 4, 2025, from the Guttmacher Institute:
* * *
To: Commissioner of Food and Drugs Martin Makary, M.D., M.P.H.
U.S. Food and Drug Administration
10903 New Hampshire Ave. Silver Spring, MD 20993
Re: Comment in Support of Citizen Petition FDA-2025-P-0377-0001
* * *
Commissioner Makary,
The Guttmacher Institute ("Guttmacher") submits
more
FDA Releases Public Communication From National Association of Manufacturers
WASHINGTON, April 28 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated April 7, 2025, from the National Association of Manufacturers:
* * *
To: Jacqueline Corrigan-Curay, J.D., M.D.
Acting Director, Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
Re: Docket FDA-2024-D-4689: Considerations for the Use of Artificial Intelligence to Supp
more
Hawley Calls on FDA to Reinstate Abortion Drug Safety Regulations: 'The Time to Act is Now'
WASHINGTON, April 28 -- Sen. Josh Hawley, R-Missouri, issued the following news release:
* * *
Hawley Calls on FDA to Reinstate Abortion Drug Safety Regulations: 'The Time to Act is Now'
Today, U.S. Senator Josh Hawley (R-Mo.) sent a letter to Food and Drug Administration (FDA) Commissioner Marty Makary about new research showing that the safety risks of the chemical abortion drug mifepristone are far greater than the FDA currently acknowledges. Senator Hawley points to Dr. Makary's recent co
more
New Hampshire Insurance Department Updates Guidance for Licensee Disclosure Requirements
CONCORD, New Hampshire, April 29 -- The New Hampshire Department of Insurance issued the following news release on April 28, 2025:
* * *
New Hampshire Insurance Department Updates Guidance for Licensee Disclosure Requirements
The New Hampshire Insurance Department (NHID) has issued updated guidance to assist insurance producers and adjusters in meeting state-mandated disclosure requirements. The bulletin clarifies the options available to licensees for reporting formal public administrative a
more
Pappas Leads NH Congressional Delegation in Pressing for Urgent Risk Assessment of Portsmouth Memorial Bridge
WASHINGTON, April 28 -- Rep. Chris Pappas, D-New Hampshire, issued the following news release:
* * *
Pappas Leads NH Congressional Delegation in Pressing for Urgent Risk Assessment of Portsmouth Memorial Bridge
Following the Francis Scott Bridge tragedy last year, Portsmouth's Memorial Bridge was identified by NTSB to lack up-to-date vulnerability assessments
Today Congressman Chris Pappas (NH-01), a member of the House Transportation and Infrastructure Committee, led Senator Jeanne Shaheen
more
|
Sign up to Receive this newsletter every day via email.